Infertility Treatment Doubles the Risk of Postpartum Heart Disease
Rutgers University-New BrunswickRutgers Health researchers tie infertility treatment to a particular risk for hypertensive diseases.
Rutgers Health researchers tie infertility treatment to a particular risk for hypertensive diseases.
Americans have gotten used to seeing their doctors and other health care providers using telehealth video visits. But a new study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care. The more professional, the better.
Lung cancer remains the leading cause of cancer-related deaths worldwide, with a significant portion of these deaths attributed to the aggressive nature of the disease and its resistance to traditional treatments. The study's findings offer a promising new avenue for therapeutic intervention by targeting the interaction between neutrophils and lung cancer cells, potentially improving patient outcomes.
According to a review published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer, certain combinations of medication or psychotherapy in conjunction with transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) are supported by clinical studies for treatment of major depressive disorder (MDD). The authors do caution that, overall, the research has important limitations.
Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
Nasal chemosensation is considered the evolutionarily oldest mammalian sense and, together with somatosensation, is crucial for neonatal well-being before auditory and visual pathways start engaging the brain.
Unbound Medicine, a pioneer in knowledge management solutions for healthcare, announces the expansion of Unbound Intelligence (UBI), a groundbreaking union of artificial intelligence (AI) and human expertise, into its end-to-end platform.
New research led by Children’s Hospital Los Angeles has found that racial and socioeconomic disparities contribute to delayed care for craniosynostosis—a rare birth defect that occurs when a baby’s skull bones close too early.In the study, being Black/African American, having public insurance and living in an economically disadvantaged area were all risk factors for presenting for a first consultation at older ages.
Leptospirosis is an illness caused by a bacteria called leptospira that can be present in soil and stagnant water. Rodents and other wildlife carry the bacteria and spread it through their urine. Both humans and dogs can become sick with leptospirosis, while cats are considered disease-resistant. For both people and dogs, the result of infection can range from mild to deadly serious.
The Federation of State Physician Health Programs (FSPHP) is pleased to announce that Dr. Michael Baron’s two-year term as President began following the FSPHP’s 2024 Annual Member Business Meeting.
MedStar Washington Hospital Center is the first in the greater Washington and Baltimore regions to use the FARAPULSE™ Pulsed Field Ablation (PFA) System, an innovative cardiac ablation therapy to treat atrial fibrillation (AFib), the most common heart rhythm disorder in adults. Traditional ablation therapies have relied on heat or cold energy to block the abnormal electrical signals responsible for AFib.
Restoring motor control and sensation from an artificial hand in a natural way remains a scientific “holy grail.” Researchers have developed a novel biohybrid neuro-prosthetic research platform comprised of a dexterous artificial hand electrically interfaced with biological neural networks. Ultimately, this could lead to a better understanding of the complex sensation of touch, which is necessary for refined control of the hand.
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announces today its partnership with PreventionGenetics, a part of Exact Sciences, as its new genetic laboratory partner for the My Retina Tracker Genetic Testing Program.
It’s no secret that the Mediterranean diet is good for your health. Already recommended to reduce the risks of bowel cancer, heart disease, and dementia, new research from the University of South Australia shows that the Mediterranean diet can also reduce symptoms of stress and anxiety.
A major UK study led by health experts at the University of Stirling has found that offering financial incentives is effective in helping men to lose weight.
Results from an Iowa State University pilot study indicate three months of exercise benefits vascular health, but improving brain blood flow may require more time.
A newly published study found that one in five U.S. adults who die by suicide spent at least one night in jail in the year prior to their death. Rapidly and efficiently providing prevention, screening and outreach resources for this group is critical to reducing adult suicides nationwide.
Scientists at St. Jude Children’s Research Hospital uncovered a route to blocking activity of protein notorious for eliminating drugs, offering a potential boon to cancer therapy.
By completely or even partially depleting a protein called midnolin in B cells, UT Southwestern Medical Center researchers suppressed leukemia and lymphoma in a mouse model genetically prone to these cancers. Their findings, reported in the Journal of Experimental Medicine, could lead to new treatments for these diseases that avoid the serious side effects of current therapies.
A research team led by the University of California, Irvine has revealed the link between the frequency of sleep apnea events during the rapid-eye-movement stage and the severity of verbal memory impairment in older adults at risk for Alzheimer’s disease. Verbal memory refers to the cognitive ability to retain and recall information presented through spoken words or written text and is particularly vulnerable to Alzheimer’s.
During a congressional briefing today, leaders from American Association of Nurse Anesthesiology (AANA), along with associations representing other advanced practice registered nurses (APRNs), outlined how current Centers for Medicare & Medicaid Services (CMS) billing and care restrictions are out of line with many state laws and briefed on a current legislative solution to address these outdated barriers.
Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.
A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.
عادةً ما تكون المعالجة الكيميائية هي العلاج الأول الذي يحاول الأطباء اتباعه لعلاجاللمفومة, بما في ذلك الشكلين الأكثر شيوعًا للمرض وهما:اللِمْفُومة اللَاهودجكينيواللِمْفُومة الهودجكيني. لكن بدائل المعالجة الكيميائية آخذة في التطور، مثل علاجات الخط الأول والخيارات الاحتياطيةهذا ما يوضحه ستيفن أنسيل، دكتور في الطب، دكتوراه الفلسفة, المعتلي كرسي الدَّمَوِيَّات وأخصائي أورام الدَّمَوِيَّات فيمركز مايو كلينك الشامل للسرطان.
A quimioterapia é geralmente o primeiro tratamento que os médicos tentam para tratar um linfoma, incluindo as duas formas mais comuns: o não Hodgkin e o Hodgkin. Mas alternativas à quimioterapia estão se desenvolvendo, como os tratamentos de primeira linha e as opções de backup, explica o Ph.D e Dr. Stephen Ansell, com cadeira na área de hematologia e hematologista oncológico no Centro Oncológico Integral da Mayo Clinic.
La quimioterapia suele ser el primer tratamiento que intentan los médicos para tratar un linfoma, incluyendo las dos formas más comunes: no Hodgkin y el Hodgkin. Pero se están desarrollando alternativas a la quimioterapia, como los tratamientos de primera línea y las opciones de respaldo, explica el Ph.D y Dr. Stephen Ansell, con cátedra en el área de hematología y hematólogo oncológico en el Centro Oncológico Integral de Mayo Clinic.
Changing people’s behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.
The Kansas Institute for Precision Medicine (KIPM) will continue its mission to improve health care by training physicians and scientists in precision medicine and supporting their research, thanks to a renewed Centers of Biomedical Research Excellence (COBRE) award from the National Institute of General Medical Sciences, part of the National Institutes of Health.
Michelle Usher knew something was wrong when she became too tired to hold a paint brush or read a book. The avid oil painter and voracious reader could devour 100 novels and memoirs a year until late 2022, when overwhelming exhaustion set in.
Cedars-Sinai has named Stephanie Cohen as its new vice president of Government and Industry Relations. Cohen will play a vital role advocating for healthcare delivery, research, education and community benefit priorities with local, state and national policymakers.
Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.
Kristin Smedley is an award-winning author, TEDx speaker, trailblazer for the disability community, and mother of three children, two of whom were born blind. “Thriving Blind: Succeeding Without Sight” will be the theme of her keynote talk at the Glaucoma Patient Summit in Philadelphia.
Houston’s Mobile Stroke Unit (MSU), the first specialized ambulance for pre-hospital stroke treatment in the United States, has a new look and updated imaging and treatment capabilities.
Chemotherapy is usually the first treatment doctors try to treat lymphoma, including the two most common forms: non-Hodgkin and Hodgkin. But alternatives to chemotherapy are developing, as first-line treatments and as backup options, explains Stephen Ansell, M.D., Ph.D., hematology chair and hematologic oncologist at the Mayo Clinic Comprehensive Cancer Center.
Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for risk of developing certain health conditions or traits that arise from more than one gene. Only about one-third of respondents approved of using the technology to predict traits unrelated to disease. Nearly all expressed concerns about potential negative outcomes for individuals or society. Findings underscore need for public education about benefits, limitations, ethical hazards of polygenic risk scores for embryos.
Sleep Consortium, in partnership with leading sleep-related patient advocacy organizations, the global patient community, and key industry stakeholders, is thrilled to announce the launch of the Sleep Data Collection Platform (DCP).
Tennessee Gov. Bill Lee signed into law Senate Bill 1720/House Bill 2451, a vital patient protection measure that prevents the misleading use of medical specialty titles, including “anesthesiologist” and “anesthesiology” by unqualified individuals.
In a new research commentary, the Artificial Intelligence in Sleep Medicine Committee of the American Academy of Sleep Medicine highlights how artificial intelligence stands on the threshold of making monumental contributions to the field of sleep medicine.
A new licensing program has been released to expand access to vital life-saving training for individuals and communities. The STOP THE BLEED® Instructor Licensing Program is designed for professionals eager to teach STOP THE BLEED® techniques to their communities and organizations. Registration for this free program takes only minutes via an online application, enabling swift involvement while supporting approved instructors.
A new survey from the American Academy of Dermatology revealed that Generation Z adults, ages 18-25, are at risk for skin cancer due to increasing rates of tanning and burning. To encourage safe sun habits, the AAD is shining a spotlight on the ways that people can protect themselves from the most common and one of the most preventable types of cancer — skin cancer — this May for Skin Cancer Awareness Month.
Hackensack Meridian Hackensack University Medical Center and Hackensack Meridian Jersey Shore University Medical Center cardiologists have treated their first patients this week with the Medtronic PulseSelect Pulsed Field Ablation (PFA) System.
OCuSOFT Inc., member company of the Southwest Research & Technology Center (SWRTC) housed on its campus grounds, is pleased to announce the licensing of its patented OCuSOFT® Lid Scrub® PLUS formulation to Primera Medical Solutions for use in various capacities.
F. William Studier, a senior biophysicist emeritus at the U.S. Department of Energy's 'Brookhaven National Laboratory, has won the 2024 Richard N. Merkin Prize in Biomedical Technology for his development in the 1980s of an efficient, scalable method of producing RNA and proteins in the laboratory.
Engineers at the University of California San Diego have discovered that some brain cells age more rapidly than others, and they are disproportionately abundant in individuals afflicted with Alzheimer’s disease. Additionally, researchers observed sex-specific differences in the aging process of certain brain cells, with the female cortex exhibiting a higher ratio of “old” oligodendrocytes to “old” neurons compared to the male cortex.
Xylazine, often found in street-drug combo with fentanyl, was thought to only bind to the α2-adrenergic receptor, but UNC-Chapel Hill scientists discovered it also binds to opioid receptors, which could have profound impacts on fentanyl overdose treatment.
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD). Published in Genome Medicine on May 13, their study highlights the potential for joint therapeutic strategies to target these two challenging disorders.